Journal Title
Title of Journal: Clin Rheumatol
|
Abbravation: Clinical Rheumatology
|
Publisher
Springer London
|
|
|
|
Authors: Carlos Pineda Carlo V CaballeroUribe
Publish Date: 2015/07/17
Volume: 34, Issue: 1, Pages: 5-7
Abstract
Latin America LA is a multicultural region with an estimate of just over 600 million inhabitants displaying great heterogeneity among their nations LA countries exhibit complex demographic characteristics because of the interaction of factors such as the different ethnic background of its population a history of colonialism and varying immigration patterns resulting in a diversified population that differs in every country within the region 1The LA region has experienced a health transition characterized by fast and complex epidemiological changes in the past decades combining increasing rates of noncommunicable diseases and injuries while keeping uncontrolled many existing endemic and emerging diseasesThe national health care systems within the LA area are heterogeneous in their organizational structure and complex in their operational configuration and in the principles guiding the public and private sector roles in the provision of health care services In LA medical attention for rheumatoid arthritis RA faces a dual challenge on one side competes with a budget designed to fight poverty lack of education an increasing number of patients and on the other hand the demographic and epidemiological transitions the insufficient number of rheumatologists and concentration of the workforce in large cities an insufficient budget for education and research and the backlog of accumulated problems characteristic of underdeveloped societies 2 In consequence RA is not yet considered a public health priority for the national health care systems Therefore explaining why only 56 of RA patients had access to full medical health coverage thus often excluding biologics only 58 had more than 7 years of education and 58 were of a low/lowmiddle socioeconomic status 3Previous efforts has been made to overcome this situation including the identification of barriers to health care 4 promoting access to a prompt diagnosis and treatment developing algorithms according these realities 5 educating patients and doctors 6 or estimating the economic impact of the disease in the region 7 and recently setting the standards to harmonize the treatment provided to RA patients in LA by developing a program focused in establish centers of excellence that would offer to RA patients a better care 8Additionally technological progress drug development and diagnostic capabilities advanced in the past two decades has resulted in major improvements in health outcomes for RA patients in developed countries but the cost of these innovations including joint prostheses access to biological medications and the lack of trained health personnel to deliver the specialized care still puts these out of the reach of people with RA in most low and middle income countries Education and training of health professionals also remains an unmet key priority 2Promote the educational activities and organize in conjunction with the national societies the Pan American Congress of Rheumatology as well as to promote national or regional meetings and encourage publication and dissemination of the scientific proceedings of meetings
Keywords:
.
|
Other Papers In This Journal:
- A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima–media in patients with systemic autoimmune diseases
- The virtuoso foot
- Responsiveness of the DASH score in surgically treated basal joint arthritis of the thumb: preliminary results
- RAPID3 scores and hand outcome measurements in RA patients: a preliminary study
- Bone mineral density in children with familial Mediterranean fever
- Chorea as a side effect of gabapentin (Neurontin®) in a patient with complex regional pain syndrome Type 1
- Risk factors in transient osteoporosis: a retrospective study on 23 cases
- Outcome of reactive arthritis after an extensive Finnish waterborne gastroenteritis outbreak: a 1-year prospective follow-up study
- Elevated serum TRAIL levels in scleroderma patients and its possible association with pulmonary involvement
- The autonomic nervous system in systemic sclerosis. A review
- Detection of anticardiolipin antibody IgG by time-resolved fluoroimmunoassay
- Prescription patterns and trends in anti-rheumatic drug use based on a large-scale claims database in Japan
- Rheumatoid arthritis: should we shift the focus from “Treat to Target” to “Treat to Work?”
- Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis
- Severe deficiency of 25-hydroxyvitamin D 3 (25-OH-D 3 ) is associated with high disease activity of rheumatoid arthritis
- The expression of death decoy receptor 3 was increased in the patients with primary Sjögren’s syndrome
- Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD)
- Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared
- Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge
- Group visits for rheumatoid arthritis patients: a pilot study
- Identification of transcription regulatory relationships in rheumatoid arthritis and osteoarthritis
- The impact of current health-related quality of life on future health outlook in patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome)
- Two cases demonstrating thalidomide’s efficacy in refractory lupus nephritis
- Rheumatoid arthritis among Nigerians: the first 200 patients from a rheumatology clinic
- The challenge of profound hypoglycorrhachia: two cases of sarcoidosis and review of the literature
- Chronic intestinal pseudo-obstruction in patients with systemic lupus erythematosus: report of four cases
- Relationship of Q angle and joint hypermobility and Q angle values in different positions
- Osteoarthritis of the hip or knee: which coexisting disorders are disabling?
- Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels
- T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet’s disease
- Successful treatment of a patient with primary Sjögren's syndrome with Rituximab
- Oxidative status in rheumatoid arthritis
- Impact and therapy of osteoarthritis: the Arthritis Care OA Nation 2012 survey
- Follicular bronchiolitis, an unusual cause of haemoptysis in giant cell arteritis
- Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature
- Vitamin D and systemic lupus erythematosus: state of the art
- Clostridium difficile : an under-recognized cause of reactive arthritis?
- Prevalence of rheumatic diseases in Raramuri people in Chihuahua, Mexico: a community-based study
- Clinical utility of magnetic resonance angiography (MRA) in the diagnosis and treatment of Takayasu’s arteritis
- A systematic review of homoeopathy for the treatment of fibromyalgia
- Do hip OA patients referred to orthopedic surgeons by general practitioners and rheumatologists differ?
- The pathway of estradiol-induced apoptosis in patients with systemic lupus erythematosus
- Antistreptococcal Response is Exaggerated in Children with Familial Mediterranean Fever
- High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register
- Beware of the biologicals—hospitals may die: the Rheumatism Foundation Hospital, Heinola, Finland (1951–2010)
- Patterns of pain in Paget’s disease of bone and their outcomes on treatment with pamidronate
- QT dispersion in uncomplicated familial Mediterranean fever
- Ultrasonographic evaluation of the muscle architecture in patients with systemic lupus erythematosus
- Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin
- Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis
- Autonomic dysfunction in psoriatic arthritis
- Exercise therapy for patients with diffuse idiopathic skeletal hyperostosis
- Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients
- The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis
- Increased expression of IL - 28RA mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
- Contrast-enhanced power Doppler sonography of knee synovitis in rheumatoid arthritis: assessment of therapeutic response
- Long-term follow-up of autologous stem cell transplantation for severe paediatric systemic lupus erythematosus
- Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome
- Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjects
- Evaluation of a mail-delivered, print-format, self-management program for persons with systemic sclerosis
- Serum galectin-3 level in systemic sclerosis
- Non-rheumatoid erosive arthritis associated with type I hereditary angioedema
- Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases
- Familial Mediterranean fever responds well to infliximab: single case experience
- Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases
- The role of PET/CT in Cogan’s syndrome
- Treatment of osteoporosis in renal insufficiency
- STAT4 rs7574865 G/T polymorphism is associated with rheumatoid arthritis and disease activity, but not with anti-CCP antibody levels in a Mexican population
|